Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ponatinib in Advanced GIST After Prior TKI Failure
NCT01874665Phase 2Completed
- Sponsor
- ARIAD Pharmaceuticals, Inc.
- Start
- Jun 2013
- Primary completion
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ponatinib in gastrointestinal stromal tumor (GIST), sponsored by ARIAD Pharmaceuticals, Inc.. Started Jun 2013; status: completed.
02
Drugs
ponatinib
03
Conditions
gastrointestinal stromal tumor (GIST)
Beyond the preview
Go deeper on NCT01874665.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01874665.